venture capital fund, has exited from further investments in ZenoHealth (a generic medicine startup earlier known as Generico) to focus on other early stage investment opportunities.
The fund has set aside ₹100 crore for fresh round of investments over the next 12 months and is in the process of identifying 2 to 3 new startups.Backed by Abhinandan Lodha of Lodha Group, the fund has so far invested more than ₹100 crore over the last 3 years into four startups including ZenoHealth, Bonito Designs and Multiliving Technologies.The ₹13 crore investment in ZenoHealth was in the form of debt and equity.